Q4 2024 Earnings Call Transcript February 12, 2025 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.4 ...
announced a multi-year agreement to automate assay kits on a custom Opentrons Flex ® workstation. Scientists and engineers will collaborate to develop and verify platform workflows utilizing the ...
Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...
21d
GlobalData on MSNMerck and Opentrons to automate assay kits on custom workstationMerck KGaA (Merck) and Opentrons Labworks have announced a partnership to automate assay kits on a ‘custom’ Opentrons Flex workstation. The multi-year collaboration will see scientists and engineers ...
Bioink manufacturers play an important role in bioprinting. Explore our list to see which companies are on the market.
Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...
Merck, a leading science and technology company, and Opentrons Labworks, Inc., a leader in lab automation and accessible robotics, announced a multi-year agreement to automate assay kits on a custom ...
Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...
Zacks.com on MSN28d
Why Bio-Rad Stock is an Apt Pick for Your Portfolio Right NowThe renowned manufacturer and global supplier of clinical diagnostics and life science research products has a market capitalization of $9.57 billion. Bio-Rad’s earnings surpassed estimates in each of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results